| ||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
Search results for: "N"
Results 121 - 130 of 277 shown below 
|
||||||||
|
||||||||
|
||||||||
|
||||||||
NF BD Liberg, B Lazarevic, R W Pero and T Leanderson N-substituted benzamides inhibit NF B activation and induce apoptosis by separate mechanisms
doi:10.1038/sj.bjc.6690796 Abstract | Full article | PDF |
||||||||
NF- BM De Ridder, D L Van den Berge, V N Verovski, C Monsaert, N Wauters and G A Storme NF- B inhibition impairs the radioresponse of hypoxic EMT-6 tumour cells through downregulation of inducible nitric oxide synthase
doi:10.1038/sj.bjc.6600678 Abstract | Full article | PDF H Dalen and J Neuzil  -Tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-B activation
doi:10.1038/sj.bjc.6600683 Abstract | Full article | PDF W Wang and J Cassidy Constitutive nuclear factor-kappa B mRNA, protein overexpression and enhanced DNA-binding activity in thymidylate synthase inhibitor-resistant tumour cells doi:10.1038/sj.bjc.6600753 Abstract | Full article | PDF B N Fahy, M Schlieman, S Virudachalam and R J Bold AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2 doi:10.1038/sj.bjc.6601037 Abstract | Full article | PDF A S Whitehouse and M J Tisdale Increased expression of the ubiquitin – proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF- B
doi:10.1038/sj.bjc.6601132 Abstract | Full article | PDF C Cherbonnier, O Déas, G Carvalho, G Vassal, A Dürrbach, A Haeffner, B Charpentier, J Bénard and F Hirsch Potentiation of tumour apoptosis by human growth hormone via glutathione production and decreased NF- B activity
doi:10.1038/sj.bjc.6601223 Abstract | Full article | PDF H J M Smartt, D J E Elder, D J Hicks, N A Williams and C Paraskeva Increased NF- B DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cells
doi:10.1038/sj.bjc.6601266 Abstract | Full article | PDF S M Wyke, S T Russell and M J Tisdale Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF- B activation
advance online publication, 2004-10-12 00:00:00.000; doi:10.1038/sj.bjc.6602165 Abstract | Full article | PDF S M Wyke and M J Tisdale NF- B mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin–proteasome system in skeletal muscle
advance online publication, 2005-02-15 00:00:00.000; doi:10.1038/sj.bjc.6602402 Abstract | Full article | PDF F V N Din, L A Stark and M G Dunlop Aspirin-induced nuclear translocation of NF B and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency
advance online publication, 2005-03-15 00:00:00.000; doi:10.1038/sj.bjc.6602455 Abstract | Full article | PDF J I Cohen HMG CoA reductase inhibitors (statins) to treat Epstein–Barr virus-driven lymphoma advance online publication, 2005-04-26 00:00:00.000; doi:10.1038/sj.bjc.6602561 Abstract | Full article | PDF L Lessard, L R Bégin, M E Gleave, A-M Mes-Masson and F Saad Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study advance online publication, 2005-10-04 00:00:00.000; doi:10.1038/sj.bjc.6602796 Abstract | Full article | PDF J Domingo-Domenech, B Mellado, B Ferrer, D Truan, J Codony-Servat, S Sauleda, J Alcover, E Campo, P Gascon, A Rovira, J S Ross, P L Fernández and J Albanell Activation of nuclear factor- B in human prostate carcinogenesis and association to biochemical relapse
advance online publication, 2005-11-08 00:00:00.000; doi:10.1038/sj.bjc.6602851 Abstract | Full article | PDF W-S Yeow, M F Ziauddin, J B Maxhimer, S Shamimi-Noori, A Baras, A Chua, D S Schrump and D M Nguyen Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01 doi:10.1038/sj.bjc.6603132 Abstract | Full article | PDF S D Killeen, J H Wang, E J Andrews and H P Redmond Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword? doi:10.1038/sj.bjc.6603275 Abstract | Full article | PDF W Weichert, M Boehm, V Gekeler, M Bahra, J Langrehr, P Neuhaus, C Denkert, G Imre, C Weller, H-P Hofmann, S Niesporek, J Jacob, M Dietel, C Scheidereit and G Kristiansen High expression of RelA/p65 is associated with activation of nuclear factor- B-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis
advance online publication, 2007-07-10 00:00:00.000; doi:10.1038/sj.bjc.6603878 Abstract | Full article | PDF S J Van Laere, I Van der Auwera, G G Van den Eynden, P van Dam, E A Van Marck, P B Vermeulen and L Y Dirix NF- B activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation
advance online publication, 2007-08-14 00:00:00.000; doi:10.1038/sj.bjc.6603906 Abstract | Full article | PDF X Guo, T R J Evans, S Somanath, A L Armesilla, J L Darling, A Schatzlein, J Cassidy and W Wang In vitro evaluation of cancer-specific NF- B-CEA enhancer–promoter system for 5-fluorouracil prodrug gene therapy in colon cancer cell lines
advance online publication, 2007-08-07 00:00:00.000; doi:10.1038/sj.bjc.6603930 Abstract | Full article | PDF S Van Laere, I Van der Auwera, G Van den Eynden, P Van Hummelen, P van Dam, E Van Marck, P B Vermeulen and L Dirix Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis advance online publication, 2007-09-11 00:00:00.000; doi:10.1038/sj.bjc.6603967 Abstract | Full article | PDF P Lagadec, E Griessinger, M P Nawrot, N Fenouille, P Colosetti, V Imbert, M Mari, P Hofman, D Czerucka, D Rousseau, E Berard, M Dreano and J F Peyron Pharmacological targeting of NF- B potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells
advance online publication, 2008-01-08 00:00:00.000; doi:10.1038/sj.bjc.6604082 Abstract | Full article | PDF |
||||||||
| NF-B C Ferlini, G Scambia, M Marone, M Distefano, C Gaggini, G Ferrandina, A Fattorossi, G Isola, P Benedetti Panici and S Mancuso Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines doi:10.1038/sj.bjc.6690042 Abstract | Full article | PDF K Takizawa, R Kamijo, D Ito, M Hatori, K Sumitani and M Nagumo Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF- B independent pathway
doi:10.1038/sj.bjc.6690449 Abstract | Full article | PDF J Miyakoshi and K Yagi Inhibition of I B- phosphorylation at serine and tyrosine acts independently on sensitization to DNA damaging agents in human glioma cells
doi:10.1054/bjoc.1999.0872 Abstract | Full article | PDF D C Duffey, C V Crowl-Bancroft, Z Chen, F G Ondrey, M Nejad-Sattari, G Dong and C Van Waes Inhibition of transcription factor nuclear factor- B by a mutant inhibitor-B attenuates resistance of human head and neck squamous cell carcinoma to TNF- caspase-mediated cell death
doi:10.1054/bjoc.2000.1423 Abstract | Full article | PDF |
||||||||
| NHEJ T Leong, M Chao, S Bassal and M McKay Radiation-hypersensitive cancer patients do not manifest protein expression abnormalities in components of the nonhomologous end-joining (NHEJ) pathway doi:10.1038/sj.bjc.6600897 Abstract | Full article | PDF |
||||||||
| NHL P Brennan, M Coates, B Armstrong, D Colin and P Boffetta Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia doi:10.1054/bjoc.1999.1102 Abstract | Full article | PDF |
||||||||
| NICE J S Waters and M E R O'Brien The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE) doi:10.1038/sj.bjc.6600491 Abstract | Full article | PDF O M McNally, E Delaney, R D Petty, M E Cruickshank, A W Hutcheon and D E Parkin Is optimal first-line chemotherapy deliverable in all newly diagnosed ovarian cancers? A population-based study doi:10.1038/sj.bjc.6601071 Abstract | Full article | PDF |
||||||||
| nicotinamide S P Robinson, F A Howe, M Stubbs and J R Griffiths Effects of nicotinamide and carbogen on tumour oxygenation, blood flow, energetics and blood glucose levels doi:10.1054/bjoc.2000.1144 Abstract | Full article | PDF |
||||||||
| Nifedipine O Thews, M Hummel, D K Kelleher, B Lecher and P Vaupel Nifedipine improves blood flow and oxygen supply, but not steady-state oxygenation of tumours in perfusion pressure-controlled isolated limb perfusion doi:10.1038/sj.bjc.6600611 Abstract | Full article | PDF |
||||||||
| night work E S Schernhammer and K Schulmeister Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? doi:10.1038/sj.bjc.6601626 Abstract | Full article | PDF |
||||||||
| NIH 3T3 S M Ronen, L E Jackson, M Beloueche and M O Leach Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells doi:10.1054/bjoc.2000.1663 Abstract | Full article | PDF |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2008 Cancer Research UK | ||
| |||
| Privacy Policy | |||